Gem'S "First Bear Stock" Came Out Of &Nbsp, And It Fell 50% In 5 Months.

Since this year, Gem Along with the index's downward trend, many stocks also fell sharply, some of them even created. list Since the new low.

As of yesterday (May 19th) closing, 115 GEM stocks fell more than 20% in the year, and more than 9 fell by more than 40%. Among them, the Kang Chi pharmaceutical industry (300086), which suffered the main business crisis, has the biggest decline, and its share price has been cut down. The national technology (300077) and the Sino Swiss group (300078) are threatened by the reduction of shareholders' prices.

Gem is the most "sad reminder" this year. Individual stock Non Kang Zhi pharmaceutical industry.

In February this year, CCTV broadcast adverse reactions to Ni Mei Shug Leigh's medication for children, and pushed the Kang Zhi pharmaceutical company, the largest Ni Mei Shug Leigh preparation manufacturer in China, to the top of the storm. At the same time, the major media have also reported on Ni Mei Shug Leigh, aspirin, and the safety of children's antipyretic drugs, such as aspirin, and so on. They have been widely reported, especially for Ni Mei Shug Leigh in recent years, many adverse events have given warning.

At the same time, reporters from the European Medicines Agency, the Hongkong health department and other authoritative institutions learned that Ni Mei Shug Leigh is not only recommended for children to use, its legal overseas "identity" is actually only painkillers, not antipyretic drugs, the EU also prohibits fever and cold patients. Many people in the industry believe that the Kang Chi pharmaceutical industry, which is mainly owned by Ruzhi Qing and nimesulide granules, will be greatly affected. After all, the main source of profits of Kang Zhi pharmaceutical industry is Rui Zhi Qing.

Kang Zhi pharmaceutical prospectus shows that the production and sale of Rui Zhi Qing basically determines the company's profit situation. From 2007 to 2009, the gross profit of the product accounted for 72.89%, 84.67% and 89.54% of gross profit respectively.

It is precisely because of the main business concerns, Kang Zhi pharmaceutical in mid February this year began a long decline in the road, during the period was a large-scale escape. Statistics show that as of the end of 2010, the top ten circulation shareholders of Kang Zhi pharmaceutical company were all fund companies. Among them, GF strategy preferred (270006, fund bar) and social security 603 portfolio holdings were as high as 1 million 355 thousand and 600 shares and 1 million 202 thousand and 200 shares, even in tenth of huitianfu balanced growth (519018, fund bar), the number of shares has also reached 499 thousand and 900 shares. However, by the end of the first quarter of this year, there were only two fund companies in the top ten list of tradable shareholders, and the number of shares of the tenth largest tradable shareholders also dropped to 110 thousand shares.

Trapped in the main business crisis, Kang Zhi pharmaceutical industry in the first quarter of this year, net profit fell sharply, down 55% compared to the same period. The share price continued to bottom up with the news. This week, the pharmaceutical industry has set a new low of 19 yuan since listing, and this year it has dropped 51.5%. The company is not only the biggest stock losing board in gem this year, but also the worst performing stock in the A share market.

Zhong Rui Si Chong, national technology shareholder busy cash.

The unsatisfactory results will also make the big shareholders and managers lose patience. The best example is the national technology and the intermediate group who have landed on the gem. The former is informed by the two shareholders that they will wait for the opportunity to reduce their holdings. The latter has been reduced by the deputy general manager, and the two stocks have become a pair of real "difficult brothers".

2011 is not destined to be the lucky year of national technology. Not long ago, Zhang Qi, President of the national gold card office and chairman of the China Information Industry Association, pointed out that at the end of last year, the relevant ministries convened the UnionPay and the three major telecom operators, and basically defined the 13.56MHz standard which was adopted by the UnionPay in the near field payment. The China Mobile led 2.45GHz scheme was only used in the closed application environment, and it was not allowed to enter the financial circulation field.

Zhang Qi's speech undoubtedly gave the national technology a head start, because in July 2009, the national technology and China Mobile signed a RF-SIM card's two year cooperation framework agreement. Without this agreement, perhaps national technology will not invest so much in the 2.4GHz program.

Because of this, the first quarter net profit fell by 27.16%. In May 3rd this year, many shareholders, including ZTE, welcomed the lifting of the ban on the stock market. In less than a month after the lifting of the ban, ZTE announced that it would sell the national technology stock at the right time and reasonable price range.

Although two shareholders claim to reduce their holdings, compared with the intermediate group, the national technology is still "well off". In May 4th, Zhong Ruisi created a total of 61 million 250 thousand shares held by many executives, and the lifting of the ban on sale was lifted. One day after the lifting of the ban, China and Switzerland were reduced by its deputy general manager, Yu Guohua.

In May 5th, Yu Guohua reduced 1 million shares in the bulk trading market at a price of 21.65 yuan / share, and reduced 800 thousand shares in May 9th at a price of 21.15 yuan / share. In May 10th, some shareholders held 1 million 200 thousand shares at a price of 21.24 yuan / share. Although the company did not announce that the person was Yu Guohua, the sale could still be him from the sales department. If it is true, then in just 3 trading days, Yu Guohua will reduce cash holdings of about 64000000 yuan.

Poor performance and shareholders' holdings, the share price of national technology and Sino resi is also falling. As of yesterday's close, national technology and Sino Swiss innovation are close to the new low, with two stocks falling 43.16% and 29.27% respectively this year.